doi:10.1080/07315724.2014.10719372 Sezgin E, Levental I, Mayor S, Eggeling C
Beijers RJ, Gosker HR, Sanders KJ, de Theije C, Kelders M, Clarke G, et al
The side effects such as dry mouth, acid reflux, and bacterial changes can increase the risk of cavities, enamel erosion, and gum disease
Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the rewind randomised, placebo-controlled trial
However, for some people, it does